Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Feb;17(1):3-9.
doi: 10.1007/s10157-012-0711-6. Epub 2012 Oct 26.

Nodular lesions and mesangiolysis in diabetic nephropathy

Takashi Wada  1 , Miho Shimizu, Hitoshi Yokoyama, Yasunori Iwata, Yoshio Sakai, Shuichi Kaneko, Kengo Furuichi
Affiliations
Review

Nodular lesions and mesangiolysis in diabetic nephropathy

Takashi Wada et al. Clin Exp Nephrol. 2013 Feb.

Abstract

Diabetic nephropathy is a leading cause of end-stage renal failure all over the world. Advanced human diabetic nephropathy is characterized by the presence of specific lesions including nodular lesions, doughnut lesions, and exudative lesions. Thus far, animal models precisely mimicking advanced human diabetic nephropathy, especially nodular lesions, remain to be fully established. Animal models with spontaneous diabetic kidney diseases or with inducible kidney lesions may be useful for investigating the pathogenesis of diabetic nephropathy. Based on pathological features, we previously reported that diabetic glomerular nodular-like lesions were formed during the reconstruction process of mesangiolysis. Recently, we established nodular-like lesions resembling those seen in advanced human diabetic nephropathy through vascular endothelial injury and mesangiolysis by administration of monocrotaline. Here, in this review, we discuss diabetic nodular lesions and its animal models resembling human diabetic kidney lesions, with our hypothesis that endothelial cell injury and mesangiolysis might be required for nodular lesions.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Hum Pathol. 1992 Dec;23(12):1373-9 - PubMed
    1. Hum Pathol. 2010 May;41(5):672-8 - PubMed
    1. Lab Invest. 2008 May;88(5):515-28 - PubMed
    1. Nephron. 2002 Jun;91(2):292-9 - PubMed
    1. Diabetologia. 2012 Jul;55(7):2059-68 - PubMed

Publication types

MeSH terms

LinkOut - more resources